European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.

Patients 81

Patients Food and Drug Administration Side effects Safety 81

European Pharmaceutical Review

AUGUST 23, 2022

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. governmental healthcare organisations.

Consulting 94

Consulting Medical Healthcare Healthcare 94

European Pharmaceutical Review

MARCH 1, 2023

The honeycomb-like pore structure, which can be seen in elegant cakes, fades into an irregular network with rod-like structures, which are partially collapsed and have drop-shaped ends. Int J Pharm 2004; 271(1-2): 215–24 [[link] 15129988] 2. References 1. Sinka IC, Burch SF, Tweed JH, Cunningham JC. Hancock BC, Mullarney MP.

Distribution 80

Distribution Electronics Pharmaceutical Food 80

World of DTC Marketing

MARCH 17, 2022

What treatment works in one patient may not work in another but we have to keep trying to beat cancer anyway we can. In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. In 2018 cancer patients in the U.S.

Food and Drug Administration 255

Food and Drug Administration Medical Ethics Patients 255

PM360

SEPTEMBER 15, 2022

Patient advocacy organizations, healthcare professional (HCP) groups, nonprofits, community-based organizations, artists, advertising agencies, life sciences companies, and more are all finding various ways to work together around a common goal. Patient Advocacy. But what do these collaborations look like? What makes them successful?

Education 105

Education Physicians Pharma Patients 105

Pharmaceutical Technology

JULY 10, 2008

Some companies using virtual technology have already reduced clinical trial times by 40% and reduced the number of patients required for testing by two thirds, says Arlington. Even so, current figures show firms’ biggest portion of spend is still on marketing and administration at 33.1%,

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52

Evolve Your Success

NOVEMBER 14, 2023

It’s network. You build a network in this industry. I always tell people to never burn a bridge and value your network more than anything in your career because you never know what opportunity might open up. I got acquainted through a prior network to go after an opportunity to take over a region as a regional leader.

Medical sales 52

Medical sales Medicine Medical Sales 52